NLRP3 tyrosine phosphorylation is controlled by protein tyrosine phosphatase PTPN22

¹Division of Gastroenterology and Hepatology, University Hospital Zurich, Zurich, Switzerland. ²Zurich Center for Integrative Human Physiology and ³Institute of Biochemistry, University of Zurich, Zurich, Switzerland. ⁴Clinic for Dermatology, University Hospital Zurich, Zurich, Switzerland. ⁵Department of Immunology, Genentech, San Francisco, California, USA. ⁶Seattle Children’s Research Institute, Division of Immunology, Seattle, Washington, USA. ⁷Institute of Experimental Immunology, University of Zurich, Zurich, Switzerland. ⁸Department of Internal Medicine I, University Hospital Regensburg, Regensburg, Germany.

Original citation: J Clin Invest. 2016;126(5):1783–1800. doi:10.1172/JCI83669.

Citation for this corrigendum: J Clin Invest. 2016;126(11):4388. doi:10.1172/JCI90897.

Tina Raselli and Isabelle Frey-Wagner were inadvertently omitted from the author list. The correct author and affiliations list is above. The updated author contributions section is below.

MRS performed experiments, analyzed the data, and wrote the first draft of the manuscript. SK, CG, TR, IFW, SL, KA, and WF performed experiments and were involved in data analysis. PMG and MGG were involved in vector design and subcloning. DJR and XD generated PTPN22-619W mice. HDB and EC performed experiments in keratinocytes and were involved in data analysis and interpretation. FM and BB performed experiments. ACC corrected and approved the manuscript. SS, SRV, MF, GR, and MS were involved in acquisition of patient samples. MS and GR conceived, designed, and supervised the study. All authors wrote, corrected, and approved the manuscript.

The authors regret the errors.